← Open Payments lookup

MICHELLE TALKINGTON: Open Payments

NPI 1700225638 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$428 in 25 payments from 8 companies in 2025. Trend: 2023 $89 · 2024 $55 · 2025 $428

Food & beverage: $428
CompanyPaymentsAmount
Novo Nordisk Inc7$138
AstraZeneca Pharmaceuticals LP6$96
Bayer Healthcare Pharmaceuticals Inc.3$46
Lilly USA, LLC3$46
GlaxoSmithKline, LLC.2$41
Boehringer Ingelheim Pharmaceuticals, Inc.2$32
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
Phathom Pharmaceuticals, Inc.1$11

Products named: Rybelsus, FARXIGA, Kerendia, Ozempic, TRELEGY ELLIPTA, JARDIANCE, MOUNJARO, BREZTRI.

Industry payments across TX — which companies pay providers there.